Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is trading at $75.69, about ₹7,257 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 0.36% today. Indian residents can buy Tarsus Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$73.85
Today's high
$76.21
52 week low
$53.89
52 week high
$91.53
TARS opened at $75.78, closed previously at $75.96, and has traded between $53.89 and $91.53 over the past 52 weeks.
About
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.
Key statistics
Avg. volume
892.34K
Market cap
$3.26B
P/E Ratio
-69.44
Price-to-sales ratio
5.37
Enterprise value
$3.14B
Free cash flow yield
1.89%
Debt-to-equity ratio
0.26
Return on equity
-13.53%
ROIC
-11.15%
Beta
0.54
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$451.36M
Earnings per share
-$1.59
Free cash flow
-$22.31M
Net profit margin
-7.67%
Gross margin
90.59%
EBITDA
-$53.61M
Revenue growth
146.71%
Similar securities
This is not an investment recommendation
How to buy Tarsus Pharmaceuticals from India
Indian residents can buy Tarsus Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Tarsus Pharmaceuticals and place an order
Find Tarsus Pharmaceuticals by name or by its ticker, TARS, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Tarsus Pharmaceuticals trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Tarsus Pharmaceuticals position in USD and INR. Tarsus Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Tarsus Pharmaceuticals from India
Trading and taxes when buying Tarsus Pharmaceuticals from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneTarsus Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Tarsus Pharmaceuticals stock?
Yes. Tarsus Pharmaceuticals (TARS) has been listed on NASDAQ since 2020, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Tarsus Pharmaceuticals share cost in rupees?
One Tarsus Pharmaceuticals share is $75.69 — about ₹7,257 at a USD/INR rate of 95.88 on 26 Sep 2026. Both the Tarsus Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Tarsus Pharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Tarsus Pharmaceuticals?
Yes. One Tarsus Pharmaceuticals share is $75.69, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Tarsus Pharmaceuticals.
How are gains on Tarsus Pharmaceuticals shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Tarsus Pharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does Tarsus Pharmaceuticals pay a dividend?
No. Tarsus Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Tarsus Pharmaceuticals from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Tarsus Pharmaceuticals shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Tarsus Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Tarsus Pharmaceuticals holding, its cost and its closing value.
How do I sell Tarsus Pharmaceuticals and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.